ArticleFrontiers in oncology2021

AMPD1 Is Associated With the Immune Response and Serves as a Prognostic Marker in HER2-Positive Breast Cancer.

Long Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.